You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 23, 2024

Ferric pyrophosphate citrate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for ferric pyrophosphate citrate and what is the scope of patent protection?

Ferric pyrophosphate citrate is the generic ingredient in two branded drugs marketed by Rockwell Medical Inc and is included in three NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ferric pyrophosphate citrate has thirteen patent family members in eleven countries.

Summary for ferric pyrophosphate citrate
International Patents:13
US Patents:2
Tradenames:2
Applicants:1
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 1
Clinical Trials: 11
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in ferric pyrophosphate citrate?ferric pyrophosphate citrate excipients list
DailyMed Link:ferric pyrophosphate citrate at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for ferric pyrophosphate citrate
Generic Entry Dates for ferric pyrophosphate citrate*:
Constraining patent/regulatory exclusivity:
Dosage:
FOR SOLUTION;INTRAVENOUS
Generic Entry Dates for ferric pyrophosphate citrate*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;INTRAVENOUS
Generic Entry Dates for ferric pyrophosphate citrate*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;INTRAVENOUS

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for ferric pyrophosphate citrate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rockwell Medical Technologies, Inc.Phase 3
Rockwell Medical Technologies, Inc.Phase 2
Rockwell Medical Technologies, Inc.Phase 1/Phase 2

See all ferric pyrophosphate citrate clinical trials

US Patents and Regulatory Information for ferric pyrophosphate citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate SOLUTION;INTRAVENOUS 206317-002 Sep 4, 2015 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate SOLUTION;INTRAVENOUS 206317-001 Jan 23, 2015 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Rockwell Medical Inc TRIFERIC AVNU ferric pyrophosphate citrate SOLUTION;INTRAVENOUS 212860-001 Mar 27, 2020 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ferric pyrophosphate citrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate SOLUTION;INTRAVENOUS 206317-001 Jan 23, 2015 ⤷  Sign Up ⤷  Sign Up
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate SOLUTION;INTRAVENOUS 206317-001 Jan 23, 2015 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.